Kelishadi M, Shahsavarani H, Tabarraei A, Shokrgozar M, Teimoori Toolabi L, Azadmanesh K. The chicken chorioallantoic membrane model for isolation of CRISPR/cas9-based HSV-1 mutant expressing tumor suppressor p53. PLoS ONE. 2023;18:e0286231 pubmed publisher

Walter M, Mayr F, Hanna B, Cookson V, Mortusewicz O, Helleday T, et al. NUDT22 promotes cancer growth through pyrimidine salvage. Oncogene. 2023;42:1282-1293 pubmed publisher

Guiley K, Shokat K. A Small Molecule Reacts with the p53 Somatic Mutant Y220C to Rescue Wild-type Thermal Stability. Cancer Discov. 2023;13:56-69 pubmed publisher

Ticha I, Hojny J, Michálková R, Kodet O, Krkavcová E, Hajkova N, et al. A comprehensive evaluation of pathogenic mutations in primary cutaneous melanomas, including the identification of novel loss-of-function variants. Sci Rep. 2019;9:17050 pubmed publisher

Yuan F, Wang J, Li R, Zhao X, Zhang Y, Liu B, et al. A New Regulatory Mechanism Between P53 And YAP Crosstalk By SIRT1 Mediated Deacetylation To Regulate Cell Cycle And Apoptosis In A549 Cell Lines. Cancer Manag Res. 2019;11:8619-8633 pubmed publisher

Lin S, Karoly E, Taatjes D. The human ?Np53 isoform triggers metabolic and gene expression changes that activate mTOR and alter mitochondrial function. Aging Cell. 2013;12:863-72 pubmed publisher